| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $2.34 | - | - |
| Q1'26 | $2.27 | $2.42 | +6.6% |
| Q4'25 | $2.37 | $2.58 | +9.1% |
| Q3'25 | $2.32 | $2.37 | +2.2% |
| Q2'25 | $2.16 | $2.02 | -6.7% |
| Q1'25 | $2.01 | $1.96 | -2.5% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $20.0B | - | - |
| Q1'26 | $19.4B | $19.7B | +1.3% |
| Q4'25 | $28.0B | $24.2B | -13.6% |
| Q3'25 | - | $17.9B | - |
| Q2'25 | - | $17.9B | - |
| Q1'25 | - | $18.8B | - |
Market Data
MET is currently trading at $91.87, giving MetLife, Inc. a market cap of 58.97B and a P/E ratio of 16.3. Today's range spans $91.14–$92.49, with shares opening at $92.06 and moving up $0.23 (0.3%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 70/100.
Over the past year MET has traded between $67.33 and $92.49 - the current price is +36.4% off the 52-week low and -0.7% from the high. 25 analysts cover the stock with a Buy consensus and a mean 12-month target of $93.81 (range $75.00–$106.00), implying upside of +2.1%.
The bullish case for MET is built on complementary signals: 95/100 technical score, BUY designation, and bullish sentiment at 70/100. At $91.87 (near 52-week highs within $67.33–$92.49), the stock is at a capitalization - 58.97B - where active managers can build meaningful positions without moving the market. (P/E: 16.3) That combination of signal quality and position-buildability makes this one of the more actionable large-cap setups in Financial Services.
Earnings revision cycles in large-cap Financial Services names tend to compound: when technicals confirm a BUY thesis (95/100) and news sentiment (70/100, bullish) supports the narrative, analyst upgrades follow price rather than lead it. At $91.87 (near 52-week highs), MET's position within the $67.33–$92.49 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).